Recent Blog Posts

View Post: Buy Toremifene Online
17 Nov 2009 by admin  
The former makes toremifene an excellent therapeutic agent against breast cancer. Although researchers are unclear of the precise mechanism by which toremifene kills breast cancer cells, it is known to compete with estrogen by binding ...
View Blog: Asbestos Cancer - http://asbestoscancer.updaterealtime.com/

---

View Post: RECENT DEVELOPMENTS IN HORMONAL TREATMENT
10 Nov 2009 by VeZİRH@N  
The most extensively investigated SERM other than tamoxifen in the setting of advanced breast cancer is toremifene. At least 5 randomized studies comparing toremifene 40 to 60 mg PO od with tamoxifen 20 to 40 mg PO od in postmenopausal, ...
View Blog: Untitled - http://www.birdunyabilgi.net/

---

View Post: Advanced or recurrent breast cancer endocrine therapy
16 Nov 2009 by admin  
Currently recommended for treatment of advanced breast cancer endocrine therapy to rescue drugs, including. 1. Estrogen receptor antagonist tamoxifen, toremifene; 2. Non-steroidal aromatase inhibitors anastrozole, letrozole; ...
View Blog: Breast Cancer Information Site - http://breastcancer123.org/

---

View Post: October FDA Calendar Stocks: Tricks or Treats? - BioMedReports.com
15 Oct 2009 by Mike Havrilla  
GTx Inc. (NASDAQ: GTXI) has a pending NDA for Acapodene (toremifene) 80 mg with a PDUFA action date of 10/30/09 as part of standard 10-month review cycle. Toremifene 80 mg is an oral selective estrogen receptor modulator which GTXI ... The FDA Panel endorsed use of d-mab for certain prostate cancer patients for treating bone loss from hormone ablation therapy, but rejected use of the drug in women with breast cancer being treated with aromatase inhibitors due to safety ...
View Blog: BioMedReports.Com - http://biomedreports.com/

---

View Post: On the Horizon – Estrogen Receptor Modulator Reduces Bone ...
26 Sep 2009 by Joel  
Toremifene is a selective estrogen receptor modulator similar to tamoxifen (Nolvadex®). It is approved by the US Food and Drug Administration (FDA) for the treatment of advanced breast cancer. Some researchers are also looking at ...
View Blog: Advanced Prostate Cancer - http://advancedprostatecancer.net/

---

View Post: UPDATE: GTx Shares Fall On Lack Of Approval For Bone Drug
2 Nov 2009 by admin  
The FDA said it saw deficiencies in the biopharmaceutical company's new drug application for toremifene citrate 80-milligram, which treats bone loss from a hormone treatment in prostate cancer patients. In addition to requesting that ...
View Blog: All News All The Time - http://scoop247.com/

---

View Post: fareston
20 Jul 2009 by irishka  
it's very different, and you will soon see whyâ € some scientists of the party was bored one day, so they connected a few video frames with breast cancer cell cultures treated with toremifene (fareston chemistry). ...
View Blog: health-fitness - http://fitnessanabolic.blogspot.com/

---

View Post: October FDA Calendar Stocks: Tricks or Treats?
15 Oct 2009 by Mike Havrilla  
Toremifene 80 mg is an oral selective estrogen receptor modulator which GTXI seeks to market for the prevention of bone fractures in men with prostate cancer on androgen deprivation therapy (ADT). ADT is primary treatment ... The FDA Panel endorsed use of d-mab for certain prostate cancer patients for treating bone loss from hormone ablation therapy, but rejected use of the drug in women with breast cancer being treated with aromatase inhibitors due to safety concerns. ...
View Blog: ProActive News Room Blog - http://www.proactivenewsroom.com/Blog/

---

View Post: are there any dangerous side effects from taking toremifene?
26 Apr 2009 by C Mitchell  
for use in women to treat breast cancer now they just want to prevent prostate cancer now they just want to the fda for use in women to prevent prostate cancer now they just want to treat breast cancer it has already been approved by ...
View Blog: Mens Cancer - http://mens-cancer.org/

---